Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment Competition
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Merck KGaA Donation Program Supports Schistosomiasis Control in Africa
- Details
- Category: Merck Group
![Merck KGaA Merck KGaA](/images/stories/logo/merck_kgaa.gif)
Encouraging Phase 2 Interim Data for Elotuzumab in Relapsed Multiple Myeloma
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Novo Nordisk presents positive clinical data on two investigational compounds within bleeding disorders
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](/images/stories/logo/novonordisk_b.gif)
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](/images/stories/logo/pfizer_b.gif)
Public believe China and India set to become World leaders for innovation
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy or radiotherapy by 80%
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
More Pharma News ...
- Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults with Chronic ITP
- Commitment of Novartis in advancing treatments for patients with cancer and rare diseases
- Genzyme Completes Sale of Genetic Testing Business to LabCorp
- Bristol-Myers Squibb and Alvin Ailey American Dance Theater Announce First-of-Its-Kind Collaboration
- GlaxoSmithKline to increase its shareholding in Theravance
- GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia
- Merck KGaA Announces Extension of FDA Priority Review Period for Cladribine Tablets